Utilization of FibroScan in clinical practice

Alan Bonder; Nezam Afdhal

doi:10.1007/s11894-014-0372-6

Utilization of FibroScan in clinical practice

Curr Gastroenterol Rep. 2014 Feb;16(2):372. doi: 10.1007/s11894-014-0372-6.

Authors

Alan Bonder¹, Nezam Afdhal

Affiliation

¹ Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis street Suite 8E, Boston, MA, 02215, USA.

PMID: 24452634
DOI: 10.1007/s11894-014-0372-6

Abstract

The evaluation of liver fibrosis is critical, particularly to rule out cirrhosis. Novel non-invasive tests such as transient ultrasound elastography are widely used to stage liver fibrosis as an alternative to liver biopsy, and this technology has recently been approved in the US. In this review, we discuss the performance characteristics of elastography for a variety of liver diseases and highlight practical appropriate suggestions for how to incorporate this technology into clinical practice.

Publication types

Review

MeSH terms

Cholestasis, Intrahepatic / diagnostic imaging
Coinfection / diagnostic imaging
Elasticity Imaging Techniques / methods*
Fatty Liver / diagnostic imaging
HIV Infections / complications
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / diagnostic imaging
Hepatitis, Viral, Human / diagnostic imaging
Humans
Hypertension, Portal / diagnostic imaging
Liver Cirrhosis / diagnostic imaging
Liver Diseases / diagnostic imaging*
Non-alcoholic Fatty Liver Disease
Professional Practice
Prognosis